A greater percentage of patients with low levels of eIF5A hypusination in tumor stromal lesions had TNM stage I and II tumors, whereas a greater percentage of patients with high levels of eIF5A hypusination in tumor stromal lesions had TNM stage III and IV tumors (p = 0.012; Fig. 6g). Here, EIF5A is linked to neoplasm.